Before the molecular identification of human tumor antigens, the existence of a spontaneous anti-tumor T cell response in melanoma patients was strongly suggested by the fact that CD8 cytolytic T cells (CTL), isolated from tumors and expanded for several weeks in vitro, lysed autologous melanoma cells. The gene discussed is CD8A; the disease is melanoma.